ATE347898T1 - Botulinustoxine zur behandlung von priapismus - Google Patents

Botulinustoxine zur behandlung von priapismus

Info

Publication number
ATE347898T1
ATE347898T1 AT03762011T AT03762011T ATE347898T1 AT E347898 T1 ATE347898 T1 AT E347898T1 AT 03762011 T AT03762011 T AT 03762011T AT 03762011 T AT03762011 T AT 03762011T AT E347898 T1 ATE347898 T1 AT E347898T1
Authority
AT
Austria
Prior art keywords
priapism
treating
treating priapism
botulinus
toxins
Prior art date
Application number
AT03762011T
Other languages
English (en)
Inventor
Markus K Naumann
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE347898T1 publication Critical patent/ATE347898T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03762011T 2002-06-26 2003-06-24 Botulinustoxine zur behandlung von priapismus ATE347898T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/183,221 US6776991B2 (en) 2002-06-26 2002-06-26 Methods for treating priapism

Publications (1)

Publication Number Publication Date
ATE347898T1 true ATE347898T1 (de) 2007-01-15

Family

ID=29779076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762011T ATE347898T1 (de) 2002-06-26 2003-06-24 Botulinustoxine zur behandlung von priapismus

Country Status (10)

Country Link
US (1) US6776991B2 (de)
EP (1) EP1515735B1 (de)
JP (3) JP4602762B2 (de)
AT (1) ATE347898T1 (de)
AU (1) AU2003243770B2 (de)
BR (1) BR0312099A (de)
CA (1) CA2489239C (de)
DE (1) DE60310400T2 (de)
ES (1) ES2278196T3 (de)
WO (1) WO2004002502A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360712A1 (en) * 2001-12-21 2003-07-30 The Trustees Of Columbia University In The City Of New York C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
US20040067235A1 (en) * 2002-07-29 2004-04-08 Rajiv Doshi Methods for the use of neurotoxin in the treatment of urologic disorders
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
US7655243B2 (en) 2005-07-22 2010-02-02 The Foundry, Llc Methods and systems for toxin delivery to the nasal cavity
EP1906923B1 (de) 2005-07-22 2018-01-24 The Foundry, LLC Systeme und verfahren zur freisetzung eines therapeutischen wirkstoffes
US10052465B2 (en) 2005-07-22 2018-08-21 The Foundry, Llc Methods and systems for toxin delivery to the nasal cavity
US20070240454A1 (en) 2006-01-30 2007-10-18 Brown David P Method and apparatus for continuous or batch optical fiber preform and optical fiber production
US7811586B2 (en) * 2006-05-02 2010-10-12 Allergan, Inc. Methods for alleviating testicular pain
US20070283969A1 (en) * 2006-06-12 2007-12-13 Medtronic Vascular, Inc. Method of Diagnosing and Treating Erectile Dysfunction
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
CA2723806C (en) 2008-05-09 2022-05-31 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
EP4193948A1 (de) 2009-10-27 2023-06-14 Nuvaira, Inc. Freisetzungsvorrichtungen mit kühlbaren energieemissionsanordnungen
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
EP4111995A1 (de) 2009-11-11 2023-01-04 Nuvaira, Inc. Vorrichtung zur gewebebehandlung und stenosekontrolleti
EP2649984A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose
EP2649983A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (II)
EP2649985A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (III)
EP2836193B1 (de) 2012-04-13 2018-01-31 Lubrizol Advanced Materials, Inc. Verbindungen zur hemmung neuronaler exozytose (ii)
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
WO1994000481A1 (en) * 1992-06-23 1994-01-06 Associated Synapse Biologics Pharmaceutical composition containing botulinum b complex
US5439938A (en) 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
EP0737074B1 (de) 1993-12-28 2001-08-01 Allergan Sales, Inc. Botulinumtoxine zur behandlung von hyperhydrosis
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US6203794B1 (en) * 1994-05-31 2001-03-20 Allergan Sales, Inc. Modification of clostridial toxins for use as transport proteins
US5562899A (en) * 1995-02-28 1996-10-08 Gerber; Allen Medical prevention of lacerations to the vagina and perineum
PT1011695E (pt) * 1997-07-15 2006-07-31 Univ Colorado Utilizacao de terapia com neurotoxina para tratamento de doencas da prostata
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6376460B2 (en) * 1998-08-07 2002-04-23 Flinders Technologies Pty. Ltd. Method of modulating cellular activity
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
SG99857A1 (en) * 1999-11-18 2003-11-27 Univ Singapore A method of treatment and prophylaxis
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
JP4602752B2 (ja) * 2004-01-14 2010-12-22 帝人株式会社 撚糸、撚糸の製造方法および撚糸の製造装置

Also Published As

Publication number Publication date
AU2003243770A1 (en) 2004-01-19
AU2003243770B2 (en) 2007-03-22
JP2013166792A (ja) 2013-08-29
EP1515735A1 (de) 2005-03-23
CA2489239A1 (en) 2004-01-08
WO2004002502A1 (en) 2004-01-08
ES2278196T3 (es) 2007-08-01
US6776991B2 (en) 2004-08-17
JP2005533819A (ja) 2005-11-10
US20040001865A1 (en) 2004-01-01
JP4602762B2 (ja) 2010-12-22
BR0312099A (pt) 2005-03-29
JP2010222367A (ja) 2010-10-07
EP1515735B1 (de) 2006-12-13
CA2489239C (en) 2011-10-11
DE60310400T2 (de) 2007-10-11
DE60310400D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
ATE347898T1 (de) Botulinustoxine zur behandlung von priapismus
DK1638586T3 (da) Synergistisk sammensætning til behandling af diabetes mellitus
ATE454162T1 (de) Botulinum toxin zur behandlung von magengeschwür und gastroösophagealen reflux
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
CA2406367A1 (en) Method for treating pain by peripheral administration of a neurotoxin
TW200503751A (en) Methods for treating sinus headache
NO20063300L (no) Fremgangsmater for behandling av akutt inflammasjon i dyr med p38 MAP kinaseinhibitorer
ME02785B (me) Humana anti-ngf neutrališuća antitela kao selektivni inhibitori ngf signalnog puta
ATE250932T1 (de) Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
ATE427747T1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
DK1507554T3 (da) Lactoferrin i behandlingen af maligne neoplasmer og andre hyperproliferative sygdomme
PT1492561E (pt) Metodo para tratar disturbios da glandula mamaria
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
DE50104569D1 (de) Verfahren zum behandeln von tabak
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DK1545609T3 (da) Antistoffer rettet mod oxideret apolipoprotein B
DE60141918D1 (de) Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd)
ATE412424T1 (de) Behandlung von druckgeschwüren
NO20062570L (no) Imidazo[1,2-A] pyridin derivater for behandling av stille gastroosofagial refluks
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser
DE60322395D1 (de) Antipruritisches mittel
ATE319689T1 (de) Naphthamidin-urokinasinhibitoren
NO20054532L (no) Fremgangsmater for a forhindre glukonoylering av proteiner
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties